Saturday, September 12, 2015 8:29:15 AM
ENdoTarget, at first I didn't know what to think about the term "black tea", but know after that last post some terms thrown out there were and to all, sorry for the mashed posts at times because its literally done in like 15 min's time because of day jobs one must landscape to buy PPHM : )
I just started with GRC, Stony Brook and Helena Paidassi and going back again to how important Brookhaven Lab is and I am now 100% certain that this group is one of the collaborators... they have to be, because if not... it could have turned into a National Security issue and dig deeper, the largest academic user is Stony Brook ==> exactly where Allison Stopeck landed and brought into the mix where she will have access to data, equipment..etc to truly be part of the Translation
1) Brookhaven National Lab basics
2) Alison Stopeck lured over to Stony Brook re: Translational Research and access to the best equipment, data..etc
3) BNL operated by Brookhaven Science Associates
4) BSA Board Members.... and now we have enough puzzle pieces to continue this journey, because Alison Stopeck did not just show up on the front steps of Stony Brook for no reason at all... just like there was not an initiative for CSM Clinical Supplies Management in Fargo ND with ex-Bristol Myers Squibb CEO Gerald Finken being part of the company that sabotaged Peregrine Pharmaceuticals.
5) Helena Paidassi ..part of 2011 GRC event
6) 2015 GRC sponsored by Peregrine/NIH
7) C1q => BINDS PS
Looks like there is much more of an interest behind the knowledge coming out of PS Targeting that we could all ever expect and now back to my day job. This damn day job is keeping me from solving this puzzle sooner because there are more connections coming...
------------------------------------------------
#1 BNL
Who We Are
Brookhaven National Laboratory is a multipurpose research institution funded primarily by the U.S. Department of Energy’s Office of Science. Located on the center of Long Island, New York, Brookhaven Lab brings world-class facilities and expertise to the most exciting and important questions in basic and applied science—from the birth of our universe to the sustainable energy technology of tomorrow.
We operate cutting-edge large-scale facilities for studies in physics, chemistry, biology, medicine, applied science, and a wide range of advanced technologies. The Laboratory's almost 3,000 scientists, engineers, and support staff are joined each year by more than 4,000 visiting researchers from around the world. Our award-winning history stretches back to 1947, and we continue to unravel mysteries from the nanoscale to the cosmic scale, and everything in between.
...
...
Management&Leadership
Brookhaven Lab is one of ten national laboratories overseen and primarily funded by the Office of Science of the U.S. Department of Energy. Brookhaven is operated and managed by Brookhaven Science Associates, which was founded by the Research Foundation for the State University of New York on behalf of Stony Brook University, and Battelle, a nonprofit applied science and technology organization.
...
..
One of ten national laboratories overseen and primarily funded by the Office of Science of the U.S. Department of Energy (DOE), Brookhaven National Laboratory conducts research in the physical, biomedical, and environmental sciences, as well as in energy technologies and national security. Brookhaven Lab also builds and operates major scientific facilities available to university, industry and government researchers. Brookhaven is operated and managed for DOE's Office of Science by Brookhaven Science Associates, a limited-liability company founded by the Research Foundation for the State University of New York on behalf of Stony Brook University, the largest academic user of Laboratory facilities, and Battelle, a nonprofit applied science and technology organization.
https://www.bnl.gov/about/
--------------------------------------------------------------
#2) In her role as Associate Dean for Translational Research at Stony Brook, Dr. Stopeck will ensure the most advanced oncology therapies are offered to breast cancer patients and build the program’s ongoing research in new treatments and prevention strategies. In Medical Oncology, she will serve in a leadership role of the multidisciplinary breast cancer team that provides an extensive range of clinical resources and technologies for breast cancer patients including providing individualized treatment plans for breast cancer patients.
http://sb.cc.stonybrook.edu/news/medical/141124TranslationalResearch.php
-------------------------------------------------------------
#3) BSA
Brookhaven Science Associates:
The Department of Energy’s (DOE) Brookhaven National Laboratory (BNL) is a significant asset to our country, through its scientific leadership and its economic impact not only on Long Island, but throughout all of New York state and the Northeast. Brookhaven National Laboratory is managed on behalf of DOE by Brookhaven Science Associates (BSA), a partnership between Stony Brook University and Battelle. BSA also engages six of the world’s premier research universities (Columbia, Cornell, Harvard, the Massachusetts Institute of Technology, Princeton and Yale) in the governance and oversight of the Laboratory. The combined strengths of these entities make significant contributions to BNL.
As a leading research university in close proximity to the BNL site, Stony Brook offers scientific collaborations, joint initiatives, and joint research appointments in BNL’s core research areas, and provides a variety of services to BNL staff. As the world’s largest nonprofit research organization and manager or co-manager of six DOE national laboratories, Battelle offers management systems and tools designed specifically for research. The affiliated research universities offer world-leading experts for scientific oversight as well as additional opportunities for research partnerships, joint appointments, and other forms of collaboration.
BSA is committed to the future of Brookhaven National Laboratory as both a world-leading scientific organization and as a source of technology innovation benefitting our region, our nation and our world.
Staying at the forefront of science and technology requires thoughtful planning and vigorous action. BSA is working with the scientific community and with DOE to identify the most important opportunities in BNL’s primary research areas, and to develop the capabilities necessary to exploit these opportunities. BSA also is engaging regional companies and other stakeholders, looking for ways to increase the economic and social benefits of new technologies arising from BNL research.
http://www.bsa-hq.org/about/about.php
---------------------------------------------------------------
#4 BSA Board Members
Brookhaven Science Associates is governed by a 16-member Board of Directors: Five appointed by the SUNY Research Foundation, five by Battelle, and one each from six of the nation's premier research universities: Columbia, Cornell, Harvard, Massachusetts Institute of Technology, Princeton, and Yale.
The Board is responsible for:
• Setting overall Laboratory policy and direction (see Science & Technology Steering Committee)
• Conducting an annual review of overall contract performance
• Conducting independent corporate self-assessments, and
• Providing advice and assistance to the Laboratory Director on significant scientific, technical, or management issues.
Dr. Samuel L. Stanley is the current chair of the BSA board.
The BSA Board is supported by several committees, including the Scientific & Technology Steering Committee, which commissions peer reviews of BNL's programs and scientific facilities, and advises the Board on scientific direction, user facility operation, and management and policy matters that directly affect the Laboratory's science mission.
BSA Board Members
Samuel L. Stanley, Jr., MD
BSA Board Chair
President
Stony Brook University
bio »
Ronald D. Townsend
BSA Board Vice Chair
Executive Vice President, Global Laboratory Operations
Battelle Memorial Institute
bio »
Dennis Assanis
Provost and Senior Vice President for
Academic Affairs
Stony Brook University
bio »
Charles Baltay
Yale University
Professor, Physics & Astronomy
Designee for: Richard Levin, President
bio »
Terry K. Brog
Chief Operating Officer, Energy & Environment
Pacific Northwest National Laboratory
bio »
Robert A. Buhrman
Cornell University
Senior Vice Provost for Research
Designee for: David J. Skorton, President
bio »
Dave Evans
Executive Vice President and CFO
Battelle
bio »
Robert Lourie
Head, Futures Research
Renaissance Technologies
bio »
Alfred Mueller
Columbia University
Enrico Fermi Professor of Physics
Designee for: Lee C. Bollinger, President
bio »
Richard McCullough
Harvard University
Vice Provost for Research
Designee for: Drew Gilpin Faust, President
bio »
Peter Paul
Office for Brookhaven Affairs
Stony Brook University
bio »
Erik W. Pearson
Vice President, Strategic Planning, Global Laboratory Operations
Battelle
bio »
Robert P. Redwine
Massachusetts Institute of Technology
Professor of Physics
Director, Bates Linear Accelerator Center
Designee for: L. Rafael Reif, President
bio »
James Simons
President and Chief Executive Officer
Euclidean Capital LLC
bio »
Thomas Snowberger
Senior Vice President, Human Resources
Battelle
bio »
A.J. Stewart Smith
Princeton University
Vice President, Princeton Plasma Physics Laboratory
Designee for: Shirley M. Tilghman, President
bio »
BSA Officers
Doon Gibbs
BSA President and Lab Director, Brookhaven National Laboratory
bio »
Suzanne Davidson
Chief Financial Officer, BSA and Brookhaven National Laboratory
bio »
Anne Troutman
Secretary, BSA General Counsel, Brookhaven National Laboratory
bio »
http://www.bsa-hq.org/about/board.php
---------------------------------------------------------------
5) Helena Paidassi
this was one I couldn't find much on initially, but did see she was "Chair.." of this GRC event back in 2011
Helena Paidassi
MGH/ Harvard Medical School
Chair, 2011 Apoptotic Cell Recognition & Clearance (GRS)
http://www.grc.org/GRC/chairs.aspx?chair=c13674
---------------------------------------------------------------
6) 2015 GRC ..
Related Meeting
GRCThis GRS was held in conjunction with the "Apoptotic Cell Recognition & Clearance" Gordon Research Conference (GRC). Refer to the associated GRC program page for more information.
Contributors
Generous financial support from Peregrine Pharmaceuticals is in memory of Dr. Philip E. Thorpe.
https://www.grc.org/programs.aspx?id=14625
------------------------------------------------------------
7) C1q binds PS and look who was involved? : ) keep digging deeper
C1q binds phosphatidylserine and likely acts as a multiligand-bridging molecule in apoptotic cell recognition
Helena Paidassi
Tacnet-Delorme P, Garlatti V, Darnault C, Ghebrehiwet B, Gaboriaud C, Arlaud GJ, Frachet P
http://www.ncbi.nlm.nih.gov/pubmed/16617157
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!
Recent CDMO News
- Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance • GlobeNewswire Inc. • 05/23/2024 12:05:46 PM
- Avid Bioservices to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 08:05:11 PM
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:38:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:37:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:36:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:35:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 12:56:02 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/08/2024 09:32:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:56:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:55:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:53:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:51:57 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 12/19/2023 09:05:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:34:08 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM